Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics
Sabry, S., AL-Zobaidy, M., Jody, M. (2022). Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics. EKB Journal Management System, 89(1), 5752-5757. doi: 10.21608/ejhm.2022.266040
Shelan Amer Sabry; Mohammed Abdul-Hassan Jabarah AL-Zobaidy; Mazin Jody. "Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics". EKB Journal Management System, 89, 1, 2022, 5752-5757. doi: 10.21608/ejhm.2022.266040
Sabry, S., AL-Zobaidy, M., Jody, M. (2022). 'Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics', EKB Journal Management System, 89(1), pp. 5752-5757. doi: 10.21608/ejhm.2022.266040
Sabry, S., AL-Zobaidy, M., Jody, M. Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics. EKB Journal Management System, 2022; 89(1): 5752-5757. doi: 10.21608/ejhm.2022.266040

Patients' Adherence to Capecitabine Treatment Is Affected by The Drug-Related Adverse Effects Rather Than by Their Sociodemographic Characteristics

The Egyptian Journal of Hospital Medicine
Article 255, Volume 89, Issue 1, October 2022, Page 5752-5757  XML PDF (811.58 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2022.266040
View on SCiNiTO View on SCiNiTO
Authors
Shelan Amer Sabry; Mohammed Abdul-Hassan Jabarah AL-Zobaidy email ; Mazin Jody
Abstract
Background: Colorectal cancer is the third most prevalent cancer worldwide as 1.80 million new cases of the cancer were diagnosed, and 862,000 patients died in 2018. Depending on the stage, upfront surgery is the main form of treatment, followed by adjuvant chemotherapy.Despite the importance of patients' adherence while they are on anti-cancer treatment, there was no published data in the literature evaluating this vital parameter concerning Iraqi patients receiving anti-cancer drugs, in general, or those on Capecitabine, in particular.
Methods: A cross-sectional, open-label prospective study was conducted at Al-Amal and Oncology Teaching Hospitals, Baghdad during the period from November 2021 to June 2022. A convenient sampling method was adopted to enrol patients in the current study. Assessment of adherence to capecitabine treatment was done using Morisky Medication-Taking Adherence Scale (MMAS). Results: Generalized fatigue was the most common adverse event as it presented in 63.7% of participants. Also, only 6.9% of participants had abnormal renal function tests. In addition, most of participants showed low-moderate adherence to capecitabine treatment.
Conclusion: The extent of adherence to capecitabine treatment by colorectal cancer seems to be more sensitive to capecitabine-related adverse effects rather than to patients’ sociodemographic characteristics.
 
Keywords
Adherence; Adverse effects; Capecitabine; Colorectal cancer; Sociodemographic
Statistics
Article View: 135
PDF Download: 237